BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19447592)

  • 1. Differentiation of activated monocytes into osteoclast-like cells on a hydroxyapatite substrate: an in vitro study.
    Narducci P; Nicolin V
    Ann Anat; 2009 Oct; 191(4):349-55. PubMed ID: 19447592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk of osteoblast and osteoclast precursors on mineralized collagen--towards an in vitro model for bone remodeling.
    Bernhardt A; Thieme S; Domaschke H; Springer A; Rösen-Wolff A; Gelinsky M
    J Biomed Mater Res A; 2010 Dec; 95(3):848-56. PubMed ID: 20824694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential regulation of osteoblast and osteoclast activity by surface topography of hydroxyapatite coatings.
    Costa DO; Prowse PD; Chrones T; Sims SM; Hamilton DW; Rizkalla AS; Dixon SJ
    Biomaterials; 2013 Oct; 34(30):7215-26. PubMed ID: 23830579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
    Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
    In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titanium IV ions induced human osteoclast differentiation and enhanced bone resorption in vitro.
    Cadosch D; Chan E; Gautschi OP; Meagher J; Zellweger R; Filgueira L
    J Biomed Mater Res A; 2009 Oct; 91(1):29-36. PubMed ID: 18683234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human osteoclast precursor circulates in the monocyte fraction.
    Fujikawa Y; Quinn JM; Sabokbar A; McGee JO; Athanasou NA
    Endocrinology; 1996 Sep; 137(9):4058-60. PubMed ID: 8756585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2 pathway.
    Lu X; Su N; Yang J; Huang W; Li C; Zhao L; He Q; Du X; Shen Y; Chen B; Chen L
    Biochem Biophys Res Commun; 2009 Dec; 390(3):494-9. PubMed ID: 19800312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones.
    Nicolin V; Ponti C; Narducci P; Grill V; Bortul R; Zweyer M; Vaccarezza M; Zauli G
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Oct; 286(2):945-54. PubMed ID: 16142787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
    Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
    Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
    Sanuki R; Shionome C; Kuwabara A; Mitsui N; Koyama Y; Suzuki N; Zhang F; Shimizu N; Maeno M
    Connect Tissue Res; 2010 Apr; 51(2):150-8. PubMed ID: 20001844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines.
    Toyosaki-Maeda T; Takano H; Tomita T; Tsuruta Y; Maeda-Tanimura M; Shimaoka Y; Takahashi T; Itoh T; Suzuki R; Ochi T
    Arthritis Res; 2001; 3(5):306-10. PubMed ID: 11549372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
    Yen ML; Tsai HF; Wu YY; Hwa HL; Lee BH; Hsu PN
    Mol Immunol; 2008 Apr; 45(8):2205-13. PubMed ID: 18206242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.
    Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M
    J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
    Takeshita S; Kaji K; Kudo A
    J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
    Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
    J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.